AI Prior Authorization in Medicare: What It Means for Patients
Artificial Intelligence is making its way into healthcare in new ways, and one of the most debated changes is the use of AI prior authorization in Medicare. Starting in 2025, the federal government will pilot a program where algorithms will help decide whether certain treatments are approved or denied. Millions of Medicare patients will be significantly affected by this, specifically how, and how quickly they receive care.
What Is AI Prior Authorization in Medicare?
Prior authorization refers to the process by which insurers decide if a treatment, prescription, or test will be covered before it takes place. Private insurance has relied on this process for a long while; however, traditional Medicare has avoided using it broadly. Now, with the new WISeR (Wasteful and Inappropriate Service Reduction) pilot, AI prior authorization in Medicare will be tested in six states: Arizona, Ohio, Oklahoma, New Jersey, Texas, and Washington.
The pilot will apply procedures flagged as potentially overused, such as skin and tissue substitutes, electrical nerve stimulator implants, and knee arthroscopy. People in support of the pilot believe that the AI model could cut down on waste and fraud while saving taxpayer dollars.
Why Critics Are Concerned
Physicians, patients, and lawmakers, on the other hand, are skeptical. Critics argue that AI prior authorization in Medicare may delay or block doctor-recommended treatments. While the CMS does promise that every denial will be reviewed by a human clinician, past practices in the private insurance sector suggest automation often leads to denials.
The question is, why isn’t AI being tested as rigorously as new medicines? Before the approval of a drug, it goes through years of trials to prove safety and effectiveness. With that in mind, AI tools that significantly impact patient care must also go through the same kind of testing before being rolled out.
Potential Benefits of AI in Medicare
Supporters claim AI could make prior authorization faster and more consistent. Rather than waiting days or weeks for approvals, algorithms could complete requests within minutes. AI usage could also reduce administrative burdens for providers and help Medicare stretch limited resources.
What This Means for Patients and Providers
The rollout of AI prior authorization in Medicare could mean more uncertainty for patients when seeking care. Procedures are more likely to face extra hurdles and delays, even if recommended by doctors. On the other hand, providers may encounter new administrative challenges as they navigate an unfamiliar AI-driven system.
What will be critical is transparency. Lack of clear oversight and public reporting on how AI makes these decisions, trust in Medicare and other broader healthcare systems could face a negative impact.
Final Thoughts
AI is on its way to becoming a permanent part of healthcare, but when it comes to AI prior authorization, caution is crucial. Just as medicines are tested thoroughly before being approved, AI tools must undergo careful research and long-term trials before determining who gets treatment. Moving too quickly risks harming the very patients Medicare is meant to protect.
